Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2018/9617363 http://scihub22266oqcxt.onion/10.1155/2018/9617363 C5859843!5859843 !29693019     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29693019 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29693019 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Biomed+Res+Int 2018 ; 2018 (ä): 9617363 Nephropedia Template TP {{tp|p=29693019 |t=2018. Biomarkers in Cardiorenal Syndromes |pdf=|usr=}}{{29693019 }} gab.com Text Biomarkers in Cardiorenal Syndromes JO: Biomed Res Int http://www.kidney.de/pget.php?&tw=1&pmid=29693019 #FOAvip There is a consensus that cardiorenal syndromes (CRS) are defined as the disorders of heart and kidney where acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in another. Patients with CRS have increased hospitalization and mortality rates, and thus their identification is of great implication. Biomarkers are not only predictive in heart failure or renal diseases, but also useful in identifying cardiac dysfunction in renal diseases and renal injury in heart failure. Thus, they may be applied in order to identify patients with CRS and even assess prognosis and guide therapy in these patients. However, studies on biomarkers have just begun in CRS. Future studies are essential to observe current biomarkers and find novel biomarkers in CRS so as to improve diagnosis, therapy, and prognosis of CRS. Twit Text FOAVip Biomarkers in Cardiorenal Syndromes ????Biomed Res Int http://www.kidney.de/pget.php?&tw=1&pmid=29693019 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29693019 #FOAvip English Wikipedia <ref>{{Cite pmid|29693019 }}</ref> Biomarkers in Cardiorenal Syndromes #MMPMID29693019 Fu S ; Zhao S ; Ye P ; Luo L Biomed Res Int 2018[]; 2018 (ä): 9617363 PMID29693019 show ga There is a consensus that cardiorenal syndromes (CRS) are defined as the disorders of heart and kidney where acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in another. Patients with CRS have increased hospitalization and mortality rates, and thus their identification is of great implication. Biomarkers are not only predictive in heart failure or renal diseases, but also useful in identifying cardiac dysfunction in renal diseases and renal injury in heart failure. Thus, they may be applied in order to identify patients with CRS and even assess prognosis and guide therapy in these patients. However, studies on biomarkers have just begun in CRS. Future studies are essential to observe current biomarkers and find novel biomarkers in CRS so as to improve diagnosis, therapy, and prognosis of CRS. |Biomarkers/*metabolism [MESH] |Cardio-Renal Syndrome/*metabolism/pathology [MESH] |Heart Failure/metabolism/pathology [MESH] |Humans [MESH] |Kidney Diseases/metabolism/pathology [MESH]Biomarkers in Cardiorenal Syndromes (epmc).pdf DeepDyve Pubget Overpricing